| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | YTL7A418KQ |
| InChI Key | QRGHOAATPOLDPF-VQFNDLOPSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H19FN6O2 |
| Molecular Weight | 394.41 |
| AlogP | 1.51 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 103.27 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 29.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 10000 | - | - | - | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class I
|
- | 3 | - | 5 | - | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIa
|
- | 200 | - | 5 | - | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | 2100 | - | 5 | - | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IV
|
- | 8 | - | 5 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1801250 |
| DrugBank | DB15419 |
| FDA SRS | YTL7A418KQ |
| Guide to Pharmacology | 8391 |
| PubChem | 49857317 |
| SureChEMBL | SCHEMBL22712412 |
| ZINC | ZINC000101424935 |